From Data to Duty: An Informatics Blueprint for Pediatric Oncology Trials
Pediatric Blood & Cancer · 20.11.2026
DOI: 10.1002/1545-5017.70816 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Blood & Cancer, online erschienen am 20.11.2026. Verfasst von Kirk D. Wyatt und 39 weiteren Autor:innen. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The data generated by cooperative‐group clinical trials have transformed outcomes for children with cancer, yet the infrastructure underlying their collection and use has not kept pace with advances in informatics and data science. Data collection on pediatric oncology trials remains largely manual: Clinical research assistants abstract values from medical records and key them into electronic case report forms, a process that is costly, slow, inconsistent, and error‐prone. Data are often siloed within trial networks for years after a study closes, limiting their value for secondary research, particularly for rare cancers. In this consensus blueprint, an interdisciplinary group of pediatric oncologists, clinical informaticians, data scientists, nurses, clinical research assistants, drug developers, and parent advocates outlines a pragmatic path forward across three components of the data lifecycle: collection, processing, and sharing. We argue that case report forms should be bound to standardized common data elements; that automated data abstraction from electronic health records, including via large language models with human‐in‐the‐loop validation, should replace much of today's manual abstraction; that paper chemotherapy roadmaps should be reconceived as computable artifacts; and that clinical trials data should be deposited in publicly accessible repositories with appropriate governance as soon as practically feasible. We discuss facilitators and barriers within each component, including standards adoption, regulatory complexity, financial sustainability, and workforce capacity. We propose concrete actions for funders, clinical trials networks, professional societies, and industry. The technology to achieve these goals exists today, and widespread adoption requires coordinated leadership, sustainable funding models, and a cultural shift that recognizes data stewardship as an ethical imperative and a duty to the children and families we serve.
Zitieren
APA
Wyatt, K. D., Tran, A. D., Birz, S., Watkins, M., Warner, J. L., Wasserstrom, H., Rossi, G. E., Rubin, E., Phillips, C. A., Waanders, A. J., Noyd, D. H., Wood, N., Schore, R. J., Alexander, N., Furner, B., Liang, W. H., Wilkes, J., Ding, Y. Y., Perumbeti, A., …, & Aplenc, R. (2026). From Data to Duty: An Informatics Blueprint for Pediatric Oncology Trials. Pediatric Blood & Cancer. https://doi.org/10.1002/1545-5017.70816
Vancouver
Wyatt KD, Tran AD, Birz S, Watkins M, Warner JL, Wasserstrom H, et al. From Data to Duty: An Informatics Blueprint for Pediatric Oncology Trials. Pediatric Blood & Cancer. 2026. doi:10.1002/1545-5017.70816
BibTeX
@article{Wyatt2026,
author = {Wyatt, Kirk D. and Tran, Andrew D. and Birz, Suzi and Watkins, Michael and Warner, Jeremy L. and Wasserstrom, Heather and Rossi, Grace E. and Rubin, Elyssa and Phillips, Charles A. and Waanders, Angela J. and Noyd, David H. and Wood, Nicole and Schore, Reuven J. and Alexander, Natasha and Furner, Brian and Liang, Wayne H. and Wilkes, Jennifer and Ding, Yang Yang and Perumbeti, Ajay and Miller, Tamara P. and Lewing, Karen and Hills, Gerard and Moore, Colin and Shliakhtsitsava, Ksenya and Benning, Tyler J. and Keller, Anna and Webb, Emily M. and Humann, Hope and Larimer, Emily and Hochheiser, Harry and Yan, Adam P. and Mian, Amir and Haddock, Amanda and Moss, Parker and Talman, Molly S. and Villagomez, Lynda M. and Jagu, Subhashini and Chen, Allen R. and Dryden, Sara M. and Aplenc, Richard},
title = {From Data to Duty: An Informatics Blueprint for Pediatric Oncology Trials},
journal = {Pediatric Blood & Cancer},
year = {2026},
doi = {10.1002/1545-5017.70816}
}
EUVIMED